Advocacy Actions
Comments to the NPCSC' Public Consultation on the Export Control Law (Second Draft)
On 14 August, the Chamber sent comments to the Standing Committee of National People's Congress on its public consultation of the Export Control Law (Second Draft).
Read moreComments to the NPCSC's Public Consultation on the Administrative Penalty Law (Revised Draft)
On 14 August, the Chamber sent comments to the Standing Committee of National People's Congress on its public consultation of the Administrative Penalty Law (Revised Draft).
Read moreMeeting with Shanghai Municipal Administration for Market Regulation on Compliance Guideline
On 14th August, European Chamber representatives met with the anti-monopoly office led by deputy director Wang Zheng of the Shanghai Municipal Administration for Market Regulation to discuss their latest Compliance Guidelines for Competition Among Business Operators (Draft for Comment).
Read more5th Shanghai Government Dialogue
5th Shanghai Government Dialogue
Read moreComments to the Standing Committee of the National People's Congress on the Data Security Law (Draft for Comments)
The European Chamber submitted collated comments on the Data Security Law (draft) to the Standing Committee of the National People's Congress.
Read moreCall with Xu Qiyuan, Director of economic development division of the Institute of World Economics and Politics (IWEP) at the Chinese Academy of Social Sciences (CASS)
On 13th August, the Working Group Coordinator of the Banking & Securities Working Group, Pablo Galvez, had a phone call conversation with Xu Qiyuan, Director of economic development division of the Institute of World Economics and Politics (IWEP) at the Chinese Academy of Social Sciences (CASS), and some of his colleagues, to explain the perspectives of foreign banks on the financial opening up and the current trends we are seeing.
Read moreMeeting with Guangzhou Development District Investment Promotion Bureau on Development of the Medical Device Industry
The Healthcare Equipment (HCE) Working Group hold a meeting with the Guangzhou Development District Investment Promotion Bureau on Development of the Medical Device Industry.
Read moreComments to the NHSA on the Adjustment Work Plan of the National Reimbursement Drug List
Comments to the NHSA on the Adjustment Work Plan of the National Reimbursement Drug List
Read moreSent the Review Report of the Center for Medical Device Evaluation Reform to the National Medical Products Administration and the Center for Medical Device Evaluation
On 11 August, the medical device sector sent the review report of the Center for Medical Device Evaluation Reform to the National Medical Products Administration and the Center for Medical Device Evaluation.
Read moreOnline meeting with representatives from ASIFMA on collaboration opportunities.
On 11th August, the Banking & Securities Working Group Coordinator, Pablo Galvez, had an online meeting with Mr. Matthew Chan, Executive Director and Head of Policy and Regulatory Affairs at ASIFMA, and Lyndon Chao, Managing Director of ASIFMA’s Equities Division, to discuss how both organisations can better work together in the future for pushing together on key issues of the industry.
Read more